Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways

Virology

Volumn 258, Issue 2, 1999, Pages 435-440

  Zhou, Aimin ^a   Paranjape, Jayashree M ^a   Der, Sandy D ^a   Williams, Bryan R G ^a   Silverman, Robert H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ANTIVIRUS AGENT; MYXOVIRUS RESISTANCE PROTEIN; PROTEIN KINASE R; RECOMBINANT ALPHA INTERFERON; RIBONUCLEASE; SYNTHETASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; EMBRYO; ENCEPHALOMYOCARDITIS VIRUS; FIBROBLAST; HOST RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; SURVIVAL TIME; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION;

ANIMALIA; ENCEPHALOMYOCARDITIS VIRUS; RNA VIRUSES; VESICULAR STOMATITIS VIRUS;

EID: 0033526512     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9738     Document Type: Article

References (23)

1. Arnheiter H., Frese M., Kambadur R., Meier E., Haller O. Mx transgenic mice: Animal models of health. Curr. Topics Microbiol. Immunol. 206:1996;119-147.
2. Clemens M., Williams B. R. G. Inhibition of cell-free protein synthesis by pppA2′p5′A2p5′A: A novel oligonucleotide synthesized by interferon-treated L cell extracts. Cell. 13:1978;565-572.
3. Der S. D., Yang Y. L., Weissmann C., Williams B. R. G. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc. Natl. Acad. Sci. USA. 94:1997;3279-3283.
4. Der S. D., Zhou A., Paranjape J., Williams B. R. G., Silverman R. H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA. 95:1998;15623-15628.
5. Gangemi J. D., Matter A., Poncioni B., Hochkeppel H. K. Significant differences in therapeutic responses to a human interferon-alpha B/D hybrid in Rauscher or Friend murine leukemia virus infections. J. Interferon Res. 9:1989;275-283.
6. Johnson V. A., Byington R. E. Quantitative assays for virus infectivity. Aldovini A., Walker B. D. Techniques in HIV Research. 1990;71-76 Stockton, New York.
7. Kerr I. M., Brown R. E. pppA2′p5′A2′p5′A: An inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treat cells. Proc. Natl. Acad. Sci. USA. 75:1978;256-260.
8. Kumar A., Yang Y. L., Flati V., Der S., Kadereit S., Deb A., Haque J., Reis L., Weissmann C., Williams B. R. G. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: Role of IRF-1 and NF-kappaB. EMBO J. 16:1997;406-416.
9. Lebleu B., Sen G. C., Shaila S., Cabrer B., Lengyel P. Interferon, double-stranded RNA and protein phosphorylation. Proc. Natl. Acad. Sci. USA. 73:1976;3107-3011.
10. Meurs E. F., Chong K., Galabru J., Thomas N. S., Kerr I. M., Williams B. R. G., Hovanessian A. G. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell. 62:1990;379-390.
11. Nolan-Sorden N. L., Lesiak K., Bayard B., Torrence P. F., Silverman R. H. Photochemical crosslinking in oligonucleotide-protein complexes between a bromine-substituted 2-5A analog and 2-5A-dependent RNase by ultraviolet lamp or laser. Anal. Biochem. 184:1990;298-304.
12. Pavlovic J., Staeheli P. The antiviral potentials of Mx proteins. J. Interferon Res. 11:1991;215-219.
13. Roberts W. K., Hovanessian A., Brown R. E., Clemens M. J., Kerr I. M. Interferon-mediated protein kinase and low-molecular-weight inhibitor of protein synthesis. Nature. 264:1976;477-480.
14. Silverman R. H., Cirino N. RNA decay by the interferon regulated 2-5A system as a host defense against viruses. Morris D. R., Harford J. B. mRNA Metabolism and Post-transcriptional Gene Regulation. 1997;295-309 John Wiley & Sons, New York.
15. Slattery E., Ghosh N., Samanta H., Lengyel P. Interferon, double-stranded RNA, and RNA degradation: Activation of an endonuclease by (2′-5′)An. Proc. Natl. Acad. Sci. USA. 76:1979;4778-4782.
16. Sokawa Y., Kitano Y., Shimada M., Okumura M., Sokawa J., Ueda K., Hamada K., Takeda K. Physiological expression of the 2-5A synthetase gene in mouse intestine. J. Interferon Res. 14:1994;121-127.
17. Staeheli P., Haller O., Boll W., Lindenmann J., Weissmann C. Mx protein: Constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell. 17:1986;147-158.
18. Staeheli P., Grob R., Meier E., Sutcliffe G., Haller O. Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol. Cell. Biol. 8:1988;4518-4523.
19. Stark G., Kerr I., Williams B. R. G., Silverman R. H., Schreiber R. How cells respond to interferons. Annu. Rev. Biochem. 67:1998;27-64.
20. Yang Y., Reis L., Pavlovic J., Aguzzi A., Schafer R., Kumar A., Williams B. R. G., Aguet M., Weissmann C. Deficient signaling in mice devoid of double-stranded RNA dependent protein kinase, PKR. EMBO J. 14:1995;6095-6106.
21. Zhou A., Hassel B. A., Silverman R. H. Expression cloning of 2-5A dependent RNase: A uniquely regulated mediator of interferon action. Cell. 72:1993;753-765.
22. Zhou A., Paranjape J., Brown T. L., Nie H., Naik S., Dong B., Chang A., Trapp B., Fairchild R., Colmenares C., Silverman R. H. Interferon action and apoptosis are defective in mice devoid of 2′-5′-oligoadenylate-dependent RNase L. EMBO J. 16:1997;3297-3304.
23. Zilberstein A., Federman P., Shulman L., Revel M. Specific phosphorylation in vitro of a protein associated with ribosomes of interferon-treated mouse L cells. FEBS Lett. 68:1976;119-124.